Edition:
United States

Ibio Inc (IBIO.A)

IBIO.A on American Stock Exchange

0.36USD
23 May 2017
Change (% chg)

$-0.01 (-2.16%)
Prev Close
$0.37
Open
$0.36
Day's High
$0.36
Day's Low
$0.36
Volume
1,030
Avg. Vol
10,857
52-wk High
$0.80
52-wk Low
$0.34

IBIO.A

Chart for IBIO.A

About

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformati... (more)
No analyst recommendations are available for IBIO.A.

Overall

Beta: 0.85
Market Cap(Mil.): $32.97
Shares Outstanding(Mil.): 89.12
Dividend: --
Yield (%): --

Financials

  IBIO.A Industry Sector
P/E (TTM): -- 14.27 17.29
EPS (TTM): -0.15 -- --
ROI: -41.96 -7.68 -5.84
ROE: -121.69 -7.30 -5.23

BRIEF-Ibio appoints James Mullaney as CFO

* On March 1, co appointed James P. Mullaney to serve as chief financial officer of company, replacing Mark Giannone

Mar 06 2017

BRIEF-iBio files for non timely 10-Q

* Ibio Inc - Files for non timely 10-Q Source text: [http://bit.ly/2lh0FiT] Further company coverage:

Feb 14 2017

More From Around the Web

Competitors

  Price Chg
Vical Incorporated (VICL.OQ) $2.31 +0.02
Novavax, Inc. (NVAX.OQ) $0.97 -0.05
Medicago Inc. (MDG.TO) -- --
Novartis AG (NOVN.S) CHF79.05 -0.35
GlaxoSmithKline plc (GSK.L) 1,629.50 -12.50
CSL Limited (CSL.AX) $131.10 +0.83
AstraZeneca plc (AZN.L) 5,141.00 +11.00
Merck Limited (MERK.NS) Rs1,029.60 -15.05

Earnings vs. Estimates